CD20-targeting CAR T cell therapy based on rituximab for the treatment of CD19-negative B cell malignancies

2020 
CD20-targeting CAR T cell therapy based on rituximab for the treatment of CD19-negative B cell malignancies
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []